| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |